NOMURA ASSET MANAGEMENT CO LTD
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1055964
TOKYO, M0
Position in ALNY
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$30,845,354
-$6,644,292 QoQ
Shares Held
93,225
-1.1% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 78.10886983916215.ToString("F0")%
Shared 0.ToString("F0")%
None 21.89113016083784.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NOMURA ASSET MANAGEMENT CO LTD holds $214,904,453 across 68 Biotechnology names. ALNY ranks #4 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
121,167 | $54,105,911 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
53,934 | $41,671,564 | |
| 3 | ARGX |
Argenx SE
|
49,306 | $36,005,704 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
93,225 | $30,845,354 | |
| 5 | INSM |
INSMED Inc
|
89,660 | $14,661,203 | |
| 6 | ASND |
Ascendis Pharma A/S
|
43,484 | $9,946,095 | |
| 7 | RPRX |
Royalty Pharma plc
|
171,980 | $8,249,880 | |
| 8 | INCY |
Incyte Corp
|
83,320 | $7,842,077 |
All Filings in ALNY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,845,354 | 93,225 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $37,489,646 | 94,278 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $40,980,264 | 89,869 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $29,796,147 | 91,374 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $23,449,346 | 86,843 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $19,480,137 | 82,785 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $23,499,937 | 85,445 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $19,269,171 | 79,297 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,917,590 | 79,743 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $13,209,393 | 69,011 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $12,045,810 | 68,017 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $12,576,496 | 66,213 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $13,481,134 | 67,298 | Shares | Sole | 2025-01-10 | |
| 2022-12-31 | $13,664,874 | 57,500 | Shares | Sole | 2025-01-10 | |
| 2022-09-30 | $11,771,008 | 58,808 | Shares | Sole | 2025-01-10 | |
| 2022-06-30 | $8,894,516 | 60,984 | Shares | Sole | 2025-01-10 | |
| 2022-03-31 | $10,272,572 | 62,910 | Shares | Sole | 2025-01-10 | |
| 2021-12-31 | $10,772,907 | 63,527 | Shares | Sole | 2025-01-10 | |
| 2021-09-30 | $8,085,599 | 42,824 | Shares | Sole | 2025-01-10 | |
| 2021-06-30 | $7,087,461 | 41,809 | Shares | Sole | 2025-01-10 | |
| 2021-03-31 | $5,734,289 | 40,614 | Shares | Sole | 2025-01-10 | |
| 2020-12-31 | $2,666,334 | 20,515 | Shares | Sole | 2025-01-10 | |
| 2020-09-30 | $2,780,232 | 19,095 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,828,160 | 19,095 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,023,521 | 18,590 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||